Skip to main content Skip to navigation

Current State

10.4

 

Average number of sites per clinical trials in the United States1

17 - 44%

 

Mean inter-laboratory coefficient of variation for flow cytometry analysis performed across 15 laboratories in HIV clinical trials2

146

 

Number of active clinical trials utilizing flow cytometry in the United States3

For 45 years, BD has been a leader in flow cytometry, partnering with scientists to drive innovation and advance scientific discovery. Leveraging this experience, the BD clinical flow cytometry solution for biopharmas and CRO labs was designed to work the way you do, making collaboration and instrument standardization across labs and continents seamless.

 

When you’re driving to be first to market, having next-generation instrumentation, software built for regulatory compliance, and reagents you can

rely on makes all the difference.

Everything you need to know

about meeting CRF Part 11 compliance

 

playIcon

Customer Testimonials

“The consistency and the regulatory compliance of the BD FACSLyric™ Flow Cytometry System’s output is what really drew us to the platform. It is currently unmatched by other flow cytometers in its ability to generate reliable, repeatable results across tests and instruments—even for the most complex assays we deal with day to day. We’ve found it particularly beneficial for multi-parameter testing for CAR T cells immunophenotyping in immune oncology for non-clinical analysis.”

 

Dr. Arno Kromminga

Chief Scientific Officer

BioAgilytix Europe

 
performance1

Discover

 

Custom Conjugates for Flow Cytometry

 

Conjugation of any fluorescent dye to any antibody within BD's portfolio or to customer-provided antivodies.

Learn More
 
performance1

BD Horizon™ Dri Chroma Panels

BD offers contract manufacturing of pre-aliquoted, performance-optimized mulicolor panels for flow cytometry in a dried down, ready to use format. The dried multicolor panels reduce inter-experiment variability and come with long shelf lives making them ideal choices for multisite and lognitudenal studies.

Learn More
 
performance1

Clinical Discovery Research Reagents

BD Biosciences Small Batch (CDRR) supply clinical researchers with tools to advance their clinical discovery.

Learn More
 
performance1

BD FACSLyric™ Flow Cytometry System

High-performance integrated solution for accurate, reliable and repeatable results across users, instruments, and sites.

Learn More
 
performance1

BD FACSuite™ Software

A true evolution in flow cytometry is empowered by BD FACSuite™ software.

Learn More
 
performance1

BD FACSLyric™ Flow Cytometer integrated with the BD FACSDuet™ Sample Preparation System

BD FACSLyricTM Flow Cytometer integrated with the BD FACSDuetTM Sample Preparation System automates the sample-to-answer process, reducing errors and limiting manual user interactions. 

Learn More
 
performance1

Speak with a flow cytometry expert


<

form submit redirect url

References

  1. Luo J, PhD, Wu M, PhD C Weiheng. Geographical Distribution and Trends of Clinical Trial Recruitment Sites in Developing and Developed Countries. Journal of Health Informatics in Developing Countries. 2017. https://pdfs.semanticscholar.org/042d/e04b7c6b81ceb95bd9808ea9240bce8c7139.pdf

  2. Maecker H, Rinfret A, D'Souza P, Darden J, Roig E. Landry C. Standardization of Cytokine Flow Cytometry Assays. National Institutes of Health. US National Library of Medicine. 2005. https://pubmed.ncbi.nlm.nih.gov/15978127n/

  3. National Institutes of Health. US National Library of Medicine. ClinicalTrials.gov. https://clinicaltrials.gov/ct2/results/details?term=flow+cyto. 2020

23-22618-00

Refer to manufacturer's instructions for use and related User Manuals and Technical Data Sheets before using this product as described.

Comparisons, where applicable, are made against older BD technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.